Is a complete ANGO research report available?

No complete published report is available for AngioDynamics, Inc. (ANGO) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

AngioDynamics, Inc. (ANGO)

NASDAQ: ANGO · USD

$13.6

+0.15 (+1.1%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-27 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first ANGO analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	561.7M
Revenue (ttm)	320.2M
Net income (ttm)	-36.7M
EPS (ttm)	-$0.88
Shares out	41.3M
Volume	332,997
Beta	0.34
Price target	$20.0	+47.2%

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 320.2M
Net income (ttm): -36.7M
EPS (ttm): -$0.88
Market cap: 561.7M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ALNY	Alnylam Pharmaceuticals, Inc.	27.4B	36.9x	5.7x	96.6%	+47.5%	-37.8%	Strong Buy
ARGX	argenx SE	53.8B	31.3x	10.1x	50.6%	+58.8%	+45.7%	Strong Buy
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

All ANGO indicators

Market & fundamental data

Available fields

229

Groups with data

Currency

USD

Showing 229 of 229 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001275187
Company name	AngioDynamics, Inc.
Country	United States
Country code	US
Cusip	03475V101
Employees	632
Employees Change	-43%
Employees Change Percent	-6.37
Enterprise value	$518.8M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Medical Instruments & Supplies
Industry PE	64.87
Industry PE Fwd	20.65
IPO Date	2004-05-27
Isin	US03475V1017
Last refreshed	2026-07-27
Market cap	$561.7M
Market cap category	Small-Cap
Price	$13.59
Price currency	USD
Rev Per Employee	506,604.43x
Sector	Healthcare
Sector PE	44.88
Sector PE Fwd	23.79
Sic	3841
Symbol	ANGO
Website	https://www.angiodynamics.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-6.54%
EV Sales Forward	1.54x
EV/FCF	1,021.26x
EV/Sales	1.62x
FCF yield	0.09%
P/B ratio	3.32x
P/S ratio	1.75x
PS Forward	1.67x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-12.47%
EBITDA Margin	-5.3%
FCF margin	0.16%
Gross margin	54.62%
Gross Profit	$174.9M
Gross Profit Growth	10.9%
Gross Profit Growth Q	10.79%
Gross Profit Growth3 Y	0.12%
Gross Profit Growth5 Y	2.21%
Net Income	$-36.7M
Net Income Growth Years	0%
Pretax Margin	-11.34%
Profit Margin	-11.48%
Profit Per Employee	$-58,136
ROA	-5.13
Roa5y	-3.86
ROCE	-20.75
ROE	-20.77
Roe5y	-24.12
ROIC	-16.35

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-1.93%
Cagr15y	-0.53%
Cagr1y	47.6%
Cagr20y	-2.71%
Cagr3y	16.25%
Cagr5y	-12.28%
EPS Growth Years	0
FCF Growth Q	-5.52%
FCF Growth5 Y	-45.31%
OCF Growth Q	-7.22%
OCF Growth10 Y	-23.54%
OCF Growth3 Y	240.86%
OCF Growth5 Y	-33.69%
Revenue Growth	9.46x
Revenue Growth Q	8.05x
Revenue Growth Quarters	5x
Revenue Growth Years	1x
Revenue Growth3 Y	-1.86x
Revenue Growth5 Y	1.93x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$1.17
Assets	$267.2M
Cash	$53.9M
Current Assets	$163.4M
Current Liabilities	$74.7M
Debt	$11M
Debt Equity	$0.06
Debt FCF	$21.57
Equity	$170.8M
Interest Coverage	-133.5
Liabilities	$96.3M
Long Term Assets	$103.8M
Long Term Liabilities	$21.6M
Net Cash	$42.9M
Net Cash By Market Cap	$7.64
Net Cash Growth	-6.21%
Net Debt Equity	$-0.25
Net Debt FCF	$-84.46
Tangible Book Value	$103.6M
Tangible Book Value Per Share	$2.48
WACC	6.04

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	2.19
Inventory Turnover	2.54
Net Working Capital	$36.5M
Quick ratio	1.37
Working Capital	$88.7M
Working Capital Turnover	$3.54

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-1.65%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-17.74%
1Y total return	47.56%
200-day SMA	11.69
3Y total return	57.11%
50-day SMA	12.44
50-day SMA vs 200-day SMA	50over200
5Y total return	-48.05%
All Time High	32
All Time High Change	-57.53%
All Time High Date	2021-11-05
All Time Low	5.26
All Time Low Change	158.37%
All Time Low Date	2024-03-25
ATR	0.61
Beta	0.34
Beta1y	0.13
Beta2y	0.23
Ch YTD	5.84
High	13.76
High52	15.2
High52 Date	2026-07-16
High52ch	-10.56%
Low	13.42
Low52	8.36
Low52 Date	2025-08-08
Low52ch	62.56%
Ma50ch	9.25%
Price vs 200-day SMA	16.23%
RSI	55.56
RSI Monthly	60.98
RSI Weekly	63.94
Sharpe ratio	1.03x
Sortino ratio	1.62
Total Return	-1.65%
Tr YTD	5.84
Tr15y	-7.61%
Tr1m	9.86%
Tr1w	0.59%
Tr3m	21.34%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	4
Analyst Count Top	0
Analyst Ratings	Strong Buy
Earnings EPS Estimate	$-0.09
Earnings Revenue Estimate	80,291,864x
Earnings Revenue Estimate Growth	0.17x
Operating Income	$-22.5M
Operating margin	-7.02
Price target	$20
Price Target Change	$47.17

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	31,773,991%
Float Percent	76.87%
Net Borrowing	-375,000
Shares Insiders	10.42%
Shares Institutions	80.93%
Shares Out	41,332,389
Shares Qo Q	0.24%
Shares Yo Y	1.65%
Short Float	4.27%
Short Ratio	3.59
Short Shares	3.28

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-13.5M
Average Volume	555,810.6x
Bv Per Share	4.1
CAPEX	$-2.6M
Ch10y	-17.74
Ch15y	-7.61
Ch1m	9.86
Ch1w	0.59
Ch1y	47.56
Ch20y	-42.29
Ch3m	21.34
Ch3y	57.11
Ch5y	-48.05
Ch6m	30.93
Change	1.12%
Change From Open	0.22
Close	13.44
Days Gap	0.89
Depreciation Amortization	22,655,000
Dollar Volume	4,525,429.2
Earnings Date	2026-07-14
Earnings Time	bmo
EBIT	$-39.9M
EBITDA	$-17M
EPS	$-0.88
F Score	5
FCF	$508,000
FCF EV Yield	0.1x
FCF Per Share	$0.01
Financing CF	564,000
Fiscal Year End	May
Founded	1,988
Income Tax	$442,000
Investing CF	-5,949,000
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-07-14
Last Report Date	2026-05-31
Last Split Type	Never
Last10k Filing Date	2026-07-14
Ma150	11.51
Ma150ch	18.12%
Ma20	13.35
Ma20ch	1.79%
Net CF	-2,029,000
Next Earnings Date	2026-10-01
Open	13.56
Optionable	Yes
P FCF Ratio	1,105.7
P OCF Ratio	181.8
Position In Range	50
Ppne	32,150,000
Price Date	2026-07-24
Ptbv Ratio	5.42
Relative Volume	0.6x
Revenue	320,174,000x
SBC By Revenue	4.36x
Share Based Comp	13,960,000
Tax By Revenue	0.14x
Tr20y	-42.29%
Tr6m	30.93%
Us State	New York
Volume	332,997
Z Score	1.67

AngioDynamics, Inc. (ANGO)

Coverage state: Market snapshot only — no published research

Generate the first ANGO analysis

Price

Financial snapshot

Fair-value bridge

Analyst consensus

Latest news · ANGO

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All ANGO indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on ANGO

Frequently asked questions